BRPI1010911A2 - "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus" - Google Patents
"anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus"Info
- Publication number
- BRPI1010911A2 BRPI1010911A2 BRPI1010911A BRPI1010911A BRPI1010911A2 BR PI1010911 A2 BRPI1010911 A2 BR PI1010911A2 BR PI1010911 A BRPI1010911 A BR PI1010911A BR PI1010911 A BRPI1010911 A BR PI1010911A BR PI1010911 A2 BRPI1010911 A2 BR PI1010911A2
- Authority
- BR
- Brazil
- Prior art keywords
- epitope
- antibodies
- fragments
- directed against
- staphylococcus aureus
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17913309P | 2009-05-18 | 2009-05-18 | |
| PCT/EP2010/056827 WO2010133600A1 (en) | 2009-05-18 | 2010-05-18 | Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1010911A2 true BRPI1010911A2 (pt) | 2019-09-24 |
Family
ID=42316060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1010911A BRPI1010911A2 (pt) | 2009-05-18 | 2010-05-18 | "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus" |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8609102B2 (pt) |
| EP (1) | EP2432804B1 (pt) |
| JP (2) | JP5882892B2 (pt) |
| CN (1) | CN102695724B (pt) |
| AU (1) | AU2010251156C1 (pt) |
| BR (1) | BRPI1010911A2 (pt) |
| CA (1) | CA2761886A1 (pt) |
| ES (1) | ES2537437T3 (pt) |
| MX (1) | MX2011012248A (pt) |
| PL (1) | PL2432804T3 (pt) |
| PT (1) | PT2432804E (pt) |
| RU (1) | RU2560415C2 (pt) |
| WO (1) | WO2010133600A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2432804B1 (en) * | 2009-05-18 | 2015-02-25 | Julius-Maximilians-Universität Würzburg | Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab |
| WO2013041707A1 (en) | 2011-09-23 | 2013-03-28 | Julius-Maximilians-Universität Würzburg | Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site |
| US9944694B2 (en) | 2013-12-13 | 2018-04-17 | Rijksuniversiteit Groningen | Antibodies against Staphylococcus aureus and uses therof |
| KR102341804B1 (ko) * | 2019-11-27 | 2021-12-22 | 주식회사 하울바이오 | 황색포도상구균을 억제하는 항-IsaA F10 항체 및 이의 용도 |
| KR102341805B1 (ko) * | 2019-11-27 | 2021-12-22 | 주식회사 하울바이오 | 황색포도상구균에 특이적으로 반응하는 항-IsaA G4 항체 및 이의 용도 |
| CA3164760A1 (en) * | 2019-12-17 | 2021-06-24 | Mie University | Methods and compositions for evaluating and treating fibrosis |
| WO2022250205A1 (ko) * | 2021-05-25 | 2022-12-01 | 주식회사 하울바이오 | 항-IsaA F10 항체의 아토피 피부염 예방 및 개선 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4238806A1 (en) | 1991-11-18 | 1993-05-27 | Dainabot Co | Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides |
| FR2746398B1 (fr) * | 1996-03-21 | 1998-04-30 | Bio Merieux | Anticorps specifique de staphylococcus aureaus, et utilisations |
| RU2144190C1 (ru) * | 1998-01-13 | 2000-01-10 | Катханов Али Муратович | Способ диагностики стафилококковой инфекции |
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| GB0127983D0 (en) | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
| AU2005324448A1 (en) * | 2005-01-10 | 2006-07-20 | Glaxosmithkline Biologicals Sa | Method of treating Staphylococcus aureus infection |
| EP2432804B1 (en) * | 2009-05-18 | 2015-02-25 | Julius-Maximilians-Universität Würzburg | Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab |
-
2010
- 2010-05-18 EP EP10720416.6A patent/EP2432804B1/en not_active Not-in-force
- 2010-05-18 BR BRPI1010911A patent/BRPI1010911A2/pt not_active IP Right Cessation
- 2010-05-18 CA CA2761886A patent/CA2761886A1/en not_active Abandoned
- 2010-05-18 WO PCT/EP2010/056827 patent/WO2010133600A1/en active Application Filing
- 2010-05-18 AU AU2010251156A patent/AU2010251156C1/en not_active Ceased
- 2010-05-18 PT PT107204166T patent/PT2432804E/pt unknown
- 2010-05-18 ES ES10720416.6T patent/ES2537437T3/es active Active
- 2010-05-18 CN CN201080021810.5A patent/CN102695724B/zh not_active Expired - Fee Related
- 2010-05-18 PL PL10720416T patent/PL2432804T3/pl unknown
- 2010-05-18 RU RU2011146424/10A patent/RU2560415C2/ru not_active IP Right Cessation
- 2010-05-18 MX MX2011012248A patent/MX2011012248A/es active IP Right Grant
- 2010-05-18 JP JP2012511263A patent/JP5882892B2/ja not_active Expired - Fee Related
- 2010-05-18 US US13/320,743 patent/US8609102B2/en not_active Expired - Fee Related
-
2013
- 2013-11-12 US US14/077,927 patent/US9260511B2/en not_active Expired - Fee Related
-
2015
- 2015-10-09 JP JP2015201433A patent/JP2016047828A/ja active Pending
- 2015-12-30 US US14/984,958 patent/US9658230B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2432804B1 (en) | 2015-02-25 |
| CN102695724B (zh) | 2016-08-24 |
| AU2010251156B2 (en) | 2014-10-09 |
| US9658230B2 (en) | 2017-05-23 |
| WO2010133600A1 (en) | 2010-11-25 |
| US20120100151A1 (en) | 2012-04-26 |
| EP2432804A1 (en) | 2012-03-28 |
| JP5882892B2 (ja) | 2016-03-09 |
| US8609102B2 (en) | 2013-12-17 |
| US20140072570A1 (en) | 2014-03-13 |
| MX2011012248A (es) | 2012-02-29 |
| CN102695724A (zh) | 2012-09-26 |
| RU2011146424A (ru) | 2013-06-27 |
| PL2432804T3 (pl) | 2015-08-31 |
| US20160109449A1 (en) | 2016-04-21 |
| AU2010251156A1 (en) | 2011-11-24 |
| US9260511B2 (en) | 2016-02-16 |
| AU2010251156C1 (en) | 2015-02-05 |
| JP2016047828A (ja) | 2016-04-07 |
| RU2560415C2 (ru) | 2015-08-20 |
| ES2537437T3 (es) | 2015-06-08 |
| JP2012527423A (ja) | 2012-11-08 |
| PT2432804E (pt) | 2015-06-25 |
| CA2761886A1 (en) | 2010-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600117B (it) | Composizioni per l'immunizzazione contro staphylococcus aureus | |
| IL217084A0 (en) | Immunogenic compositions of staphylococcus aureus antigens | |
| BRPI1015540A2 (pt) | ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750'' | |
| BRPI1010911A2 (pt) | "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus" | |
| BR112013016153A2 (pt) | composições imunogênicas estáveis de antígenos de staphylococcus aureus | |
| BRPI1010909A2 (pt) | "inseticida arilpirrolinas" | |
| BRPI0908948A2 (pt) | preparação de materiais de dessulfurização | |
| BRPI1010625A2 (pt) | "composições de pesticida incluindo adjuvantes poliméricos" | |
| BR112014004782A2 (pt) | formulações adjuvantes de antígenos de staphylococcus aureus | |
| BRPI0924425A2 (pt) | "combinações de substâncias ativas sinergéticas". | |
| BR112014025299A8 (pt) | anticorpo de reação cruzada dirigido contra staphylococcus aureus, preparação farmacêutica e diagnóstica compreendendo o anticorpo, métodos de anticorpo de reação cruzada contra staphylococcus aureus | |
| FR2934751B1 (fr) | Tondeuse de type autoportee | |
| BRPI1012174A2 (pt) | composição nanoestrutural de biocida e processo de obtenção de nanocomposição biocida nanoestrutural | |
| BRPI1011805A2 (pt) | anticorpos anti incisura-1 | |
| BRPI1007603A2 (pt) | "composição de tratamento do cabelo" | |
| BR112012004515A2 (pt) | "monitoramento por ultrassom de tratamentos estéticos" | |
| BRPI1014455A2 (pt) | "luva de fraturação universal" | |
| FR2961107B1 (fr) | Composition d'immunoglobulines humaines stabilisee | |
| FR2961381B1 (fr) | Systeme de clous d'oreilles ou piercings | |
| FR2963372B1 (fr) | Element prefabrique pour le passage de gaines techniques. | |
| BRPI0916092A2 (pt) | "isoformas específicas de anticorpos anti-her4" | |
| BRPI1013768A2 (pt) | "proteção de câmaras de amostras bioanalíticas." | |
| DK2459586T3 (da) | Proteinantigener bestemte til serodiagnostikken af Staphylococcus aureus-infektioner, specielt på knogleledsproteser | |
| BR112013007039A2 (pt) | "composição de tratamento pessoal" | |
| BRPI1012085A2 (pt) | anticorpo de resistência de plantas mediado por fusão contra oomycota |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |